Phio Pharmaceuticals announced it will present its INTASYL® siRNA gene-silencing cancer therapy platform and lead clinical program PH-762 at the National Investment Banking Association's 153rd Conference in October 2026. CEO Robert Bitterman will discuss the company's innovative approach to enhancing immune-cell function to treat skin cancers, including cutaneous squamous cell carcinoma. This presentation aims to highlight Phio's strategic direction and progress in developing a potential non-surgical treatment for skin cancer. The event also offers opportunities for one-on-one meetings to discuss the company's developments in more detail.
Phio Pharmaceuticals' upcoming presentation at the National Investment Banking Association's 153rd Conference is noted here with Pluang's Health-sector market data as of Oct 05, 2026 18:12 WIB. Of 100 priced Health-sector US stocks tradable on Pluang, 41 rose and 41 fell today. Notable movers include ENVB at USD 1.40 with a -5.41% change, HRTX at USD 0.36 with a +4.14% change, and ALGN at USD 139.68 with a -2.82% change, with HRTX showing the longest typical hold time of 35 days.
Ondas Holdings is valued similarly to established defense contractor AeroVironment despite much lower revenue and ongoing losses. AeroVironment reported $480.5 million revenue in Q1 2027 with strong backlog and profitability, while Ondas posted $83.8...
Bitmine now holds 6,016,414 ETH, about 4.9% of the total supply, and is 99% toward its goal of owning 5% of all Ethereum. It has staked over 5 million ETH, generating projected annual staking revenue of $363 million. Meanwhile, Strategy purchased 334...
AGCO Corporation has restructured its executive leadership, appointing Stefan Caspari as Senior Vice President and General Manager of Fendt/Valtra and Product Management. Caspari will also continue leading AGCO's North American agriculture business, ...
Panmure Liberum defends Plus500 after a sector sell-off triggered by IG Group's warning, maintaining a 'buy' rating and a 5,400p target. Plus500 confirmed trading in line with expectations for 2026 and holds a strong cash position, unlike IG whose re...
Gunnison Copper Corp has received pre-clearance to list on the NYSE American under the ticker "GUNN," allowing broader access for US investors. The company plans a Level II ADR program, with each ADR representing 35 common shares, expected to start t...
